Evidence map›Paper›PMID 24632136›Full record

ArticleBiosensors & bioelectronics2014

Label-free detection of cardiac troponin I with a photonic crystal biosensor.

Bailin Zhang, Andres W Morales, Ralph Peterson, Liang Tang, Jing Yong Ye

Abstract read
In one paragraph

Article in Biosensors & bioelectronics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Enhancement of label-free biosensing of cardiac troponin I.Proceedings of SPIE--the International Society for Optical Engineering · 2020
    Article
  7. Prostate Cancer Epithelial Mesenchymal Transition by TGF-β1 exposure monitored with a Photonic Crystal Biosensor.Proceedings of SPIE--the International Society for Optical Engineering · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Label-freeProceedings of SPIE--the International Society for Optical Engineering
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bailin ZhangDepartment of Biomedical Engineering, University of Texas at San Antonio, One UTSA Circle, San Antonio, TX 78249, USA.
Andres W MoralesDepartment of Biomedical Engineering, University of Texas at San Antonio, One UTSA Circle, San Antonio, TX 78249, USA.
Ralph PetersonDepartment of Biomedical Engineering, University of Texas at San Antonio, One UTSA Circle, San Antonio, TX 78249, USA.
Liang TangDepartment of Biomedical Engineering, University of Texas at San Antonio, One UTSA Circle, San Antonio, TX 78249, USA.
Jing Yong YeDepartment of Biomedical Engineering, University of Texas at San Antonio, One UTSA Circle, San Antonio, TX 78249, USA. Electronic address: jingyong.ye@utsa.edu.

Funding

Novel Optoacoustic Sensors with an Open Cavity ConfigurationR21EB008765 · NIBIB · UNIVERSITY OF TEXAS SAN ANTONIO · PI YE, JING YONG · 2008 to 2009
$394k
NIBIB NIH HHS R21 EB008765NIBIB NIH HHS R21EB008765
6 · The paper itself

Abstract

A biosensor has been developed with a photonic crystal structure used in a total-internal-reflection (PC-TIR) configuration for label-free detection of a cardiac biomarker: Troponin I (cTnI). In contrast to a conventional optical microcavity that has a closed structure with its cavity layer sandwiched between two high-reflection surfaces, the PC-TIR configuration creates a unique open microcavity, which allows its cavity layer (sensing layer) to be easily functionalized and directly exposed to analyte molecules for bioassays. In this study, a PC-TIR sensor has been used for the label-free measurements of cardiac biomarkers by monitoring the changes in the resonant condition of the cavity due to biomolecular binding processes. Antibodies against cTnI are immobilized on the sensor surface for specific detection of cTnI with a wide range of concentrations. Detection limit of cTnI with a concentration as low as 0.1ngmL(-1) has been achieved.

Indexed as

Biological AssayBiosensing TechniquesCrystallizationEquipment DesignEquipment Failure AnalysisImmunoassayMiniaturizationPhotonsRefractometryStaining and LabelingTroponin ITroponin IBioassayMyocardial infarctionOptical biosensorOptical microcavity

Identifiers

PMID24632136
PMCPMC4014604

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.